Geneva, Feb. 13 -- International Clinical Trials Registry received information related to the study (ChiCTR2600118519) titled 'A Clinical Study on the Efficacy and Safety of Hetrombopag in Preventing Thrombocytopenia Induced by Concurrent Chemoradiotherapy in Patients with Limited-Stage Small Cell Lung Cancer' on Feb. 6.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Anhui Provincial Cancer Hospital
Condition:
thrombocytopenia Induced by concurrent chemoradiotherapy in patients with limited-stage small cell lung cancer
Intervention:
Prevention Group (Phase One):hetrombopag
Non-prevention group(Phase One):none
Experimental group (Phase Two):hetrombopag
Recruitment Status: Not Recruiting
Phase: 4
Date ...